Results 111 to 120 of about 4,363 (152)

Daratumumab for CD20<sup>-</sup>CD38<sup>+</sup> Relapsed/Refractory Diffuse Large B-Cell Lymphoma. [PDF]

open access: yesJ Cell Mol Med
Hong Z   +9 more
europepmc   +1 more source

Targeting CD38 in Antibody-Mediated Rejection. [PDF]

open access: yesTranspl Int
Mayer KA   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy